Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity
- PMID: 2316621
- PMCID: PMC1877490
Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity
Abstract
We evaluated effluent blood from extremities of human patients undergoing reconstructive surgical treatment, which is routinely accompanied by upper-extremity exsanguination and application of a tourniquet, resulting in total interruption of arterial blood flow to one upper extremity. After tourniquet release (reperfusion), there were immediate increases in the plasma levels of xanthine oxidase activity, uric acid, and histamine in the ipsilateral limb and much smaller increases, if any, in levels of the same materials in plasma obtained from the contralateral extremity. There was no detectable xanthine dehydrogenase activity in plasma from either limb. Plasma also contained evidence of products consistent with the formation of oxygen-derived free radicals, namely, the appearance predominantly in the reperfused limb of hemoglobin and fluorescent compounds. These data indicate for the first time in humans that ischemia-reperfusion events are associated with the appearance of xanthine oxidase activity and its products in the plasma effluent.
Similar articles
-
Role of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients.Klin Wochenschr. 1991 Dec 15;69(21-23):1109-12. doi: 10.1007/BF01645168. Klin Wochenschr. 1991. PMID: 1798287
-
Tourniquet-induced exsanguination in patients requiring lower limb surgery. An ischemia-reperfusion model of oxidant and antioxidant metabolism.Anesthesiology. 1996 Jan;84(1):14-22. doi: 10.1097/00000542-199601000-00003. Anesthesiology. 1996. PMID: 8572327 Clinical Trial.
-
Xanthine oxidase: its role in the no-reflow phenomenon.Surgery. 1992 Feb;111(2):169-76. Surgery. 1992. PMID: 1736387
-
The role of xanthine oxidase and the effects of antioxidants in ischemia reperfusion cell injury.Acta Physiol Pharmacol Ther Latinoam. 1999;49(1):13-20. Acta Physiol Pharmacol Ther Latinoam. 1999. PMID: 10797836 Review.
-
Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion.J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):137-46. doi: 10.1007/s00534-010-0328-7. J Hepatobiliary Pancreat Sci. 2011. PMID: 20878424 Review.
Cited by
-
Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs.Inflammation. 2002 Aug;26(4):153-9. doi: 10.1023/a:1016511611435. Inflammation. 2002. PMID: 12184628
-
Drug antioxidant effects. A basis for drug selection?Drugs. 1991 Oct;42(4):569-605. doi: 10.2165/00003495-199142040-00003. Drugs. 1991. PMID: 1723362 Free PMC article. Review.
-
Integrated Microbiome and Metabolome Analysis Reveals Hypothalamic-Comorbidities Related Signatures in Craniopharyngioma.Adv Sci (Weinh). 2024 Oct;11(39):e2400684. doi: 10.1002/advs.202400684. Epub 2024 Sep 3. Adv Sci (Weinh). 2024. PMID: 39225628 Free PMC article.
-
Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome.Clin Res Cardiol. 2008 May;97(5):334-40. doi: 10.1007/s00392-007-0636-3. Epub 2007 Dec 28. Clin Res Cardiol. 2008. PMID: 18330493 Clinical Trial.
-
Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.Am J Physiol Lung Cell Mol Physiol. 2014 Nov 1;307(9):L668-80. doi: 10.1152/ajplung.00198.2014. Epub 2014 Sep 19. Am J Physiol Lung Cell Mol Physiol. 2014. PMID: 25239915 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources